These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16483351)

  • 1. TCT 2005 late-breaking trials promise to influence practice patterns.
    White J
    J Interv Cardiol; 2006 Feb; 19(1):113-6. PubMed ID: 16483351
    [No Abstract]   [Full Text] [Related]  

  • 2. TCT Daily: Cypher more effective for long lesions.
    J Interv Cardiol; 2007 Feb; 20(1):34. PubMed ID: 17300398
    [No Abstract]   [Full Text] [Related]  

  • 3. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
    Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
    J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
    Iijima R; Mehilli J; Schömig A; Kastrati A
    Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCT Daily: ESTROFA: late thrombosis not increased in DES patients: Spanish registry of drug-eluting stents shows STEMI, LAD artery lesions, significant risk factors.
    Kahn J
    J Interv Cardiol; 2007 Feb; 20(1):32. PubMed ID: 17300396
    [No Abstract]   [Full Text] [Related]  

  • 7. TCT Daily: new trials set to examine drug-eluting stents: doctors urged to weigh benefits, risks of drug-eluting stents on per patient basis.
    J Interv Cardiol; 2007 Feb; 20(1):33. PubMed ID: 17300397
    [No Abstract]   [Full Text] [Related]  

  • 8. How hospitals respond to cardiac care turmoil.
    Johnson DE
    Health Care Strateg Manage; 2004 Apr; 22(4):2-3. PubMed ID: 15141643
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings of the TCT: duration of antiplatelet therapy survey.
    Kahn J
    J Interv Cardiol; 2006 Jun; 19(3):236. PubMed ID: 16724965
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.
    Mahmud E; Bromberg-Marin G; Palakodeti V; Ang L; Creanga D; Demaria AN
    J Am Coll Cardiol; 2008 Jun; 51(25):2385-95. PubMed ID: 18565394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to treat diabetic patients with multivesseal disease in the DES era.
    Pagnotta P; Cabbavale M; Briguori C
    Minerva Cardioangiol; 2006 Oct; 54(5):557-69. PubMed ID: 17019393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
    Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
    Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.
    Nordmann AJ; Briel M; Bucher HC
    Eur Heart J; 2006 Dec; 27(23):2784-814. PubMed ID: 17020889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stent update 2007: part II: Unsettled issues.
    Daemen J; Serruys PW
    Circulation; 2007 Aug; 116(8):961-8. PubMed ID: 17709651
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A; Brodsky A; Sabapathy R; Pershad A
    Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emperor's new clothes: another cypher versus taxus post-hoc meta-analysis.
    Kereiakes DJ
    J Am Coll Cardiol; 2007 Oct; 50(14):1381-5. PubMed ID: 17903639
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-eluting stents: preventing restenosis.
    Slavin L; Chhabra A; Tobis JM
    Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proven and new--what is certain with regard to therapy in 2005?].
    Schölmerich J
    Internist (Berl); 2005 Dec; 46(12):1308-9. PubMed ID: 16187076
    [No Abstract]   [Full Text] [Related]  

  • 20. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
    Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2007 Nov; 50(21):2037-8. PubMed ID: 18021869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.